EcoDrugPlus


Keyword(s):	Natural Toxins ; Human Metabolites
Molecule Category	Free-form
UNII	4646B297U7

Keyword(s):

Natural Toxins ; Human Metabolites

Molecule Category

Free-form

UNII

4646B297U7


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	FOHHNHSLJDZUGQ-RUZDIDTESA-N
Smiles	CCCCN(CCCC)CC[C@H](c1cc2c(cc(cc2Cl)Cl)c2cc(ccc12)C(F)(F)F)O
InChI	InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3/t25-/m1/s1

InChI Key

FOHHNHSLJDZUGQ-RUZDIDTESA-N

Smiles

CCCCN(CCCC)CC[C@H](c1cc2c(cc(cc2Cl)Cl)c2cc(ccc12)C(F)(F)F)O

InChI

InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3/t25-/m1/s1

Property Name	Value
Molecular Weight	499.17
AlogP	8.64
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	10.0
Polar Surface Area	23.47
Molecular species	None
Aromatic Rings	3.0
Heavy Atoms	33.0

Property Name

Value

Molecular Weight

499.17

AlogP

8.64

Hydrogen Bond Acceptor

2.0

Hydrogen Bond Donor

1.0

Number of Rotational Bond

10.0

Polar Surface Area

23.47

Molecular species

None

Aromatic Rings

3.0

Heavy Atoms

33.0

Resources	Reference
NORMAN SUSDAT
FDA SRS	4646B297U7
PubChem	36688213

Resources

Reference

NORMAN SUSDAT

FDA SRS

4646B297U7

PubChem

36688213


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

(+)-HALOFANTRINE

Structure

Physicochemical Descriptors

Cross References